This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

About Diabetes » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Diabetes, Heart Disease Can Herald Early GI Cancers

Posted: Friday, June 02, 2006

"The presence of diabetes or heart disease can be a signal for clinicians to evaluate patients' risk for digestive cancers.” “And begin treatment with Ace inhibitors, which may reduce the risk of colon, pancreatic and esophageal cancers."

Lipid-lowering Therapy Prevents Coronary Events in Diabetics

Posted: Friday, June 02, 2006

Lipid-lowering drug treatment significantly reduced the risk of major coronary events in patients with and without type 2 diabetes, and that patients with diabetes derived more benefit from lipid-lowering therapy as primary and secondary prevention.

Bristol-Myers Squibb Discontinues Development of Pargluva

Posted: Tuesday, May 30, 2006

Researchers at the Cleveland Clinic found that Pargluva could double the risk of death, heart attack or strokes in diabetics compared to a placebo.

Grapefruit Juice Drug Interaction Culprit Identified

Posted: Wednesday, May 24, 2006

Those dangerous interactions when grapefruit juice is mixed with some drugs are apparently triggered by members of a family of plant toxins called furanocoumarins. Watch for the new Grapefruit juice to hit the supermarket shelves soon.

Scientists Make Major Finding on Potential Cure for Type 1 Diabetes

Posted: Monday, May 15, 2006

The study, which combined two therapies (anti-CD3 antibody and proinsulin peptide) already being tested individually in human clinical trials, produced better efficacy, longer-lasting results and fewer side effects in the preclinical trials in mice than either therapy has shown alone in the human studies. The researchers hope to begin testing the combination therapy in human clinical trials later this year.

Diabetes Drug Use by Children Doubled in US Over 3-Year Period

Posted: Tuesday, April 25, 2006

Between 2002 to 2005, the use of agents to prevent or treat type 2 diabetes among US children, 5 to 19 years of age, increased from about 0.3 to 0.6 per 1000, which could have "enormous implications" for long-term healthcare needs and expenses.

Once Daily ER Metformin Safe and Effective in Type 2 Diabetes

Posted: Tuesday, April 25, 2006

One daily dose of a new extended-release formulation of metformin is as safe and effective in treating type 2 diabetes as a conventional twice-a-day dose of immediate-release metformin, researchers report.

Better Initial Glycemic Control With Metformin Linked to Longer Effectiveness

Posted: Friday, April 21, 2006

In patients taking metformin as monotherapy to treat type 2 diabetes, achieving a low level of glycosylated hemoglobin level (HbA1c) during the first year predicts a longer period of effectiveness for the medication.

Newer Diabetic Meds Cost More, But Users Have Fewer Hospital Visits

Posted: Thursday, April 20, 2006

A new study suggests that patients on the newer medications had a slightly lower risk of hospitalization because of diabetes-related complications. They also spent between $920 and $1,760 less on annual total healthcare costs. Diabetics who were prescribed newer medications to control their illness were more likely to take these drugs as instructed.

Water Retention With Pioglitazone Causes Weight Gain

Posted: Thursday, April 20, 2006

Up to 75 percent of the increase in body weight that can occur in patients with type 2 diabetes who are treated with pioglitazone is from water retention but the drug also tends to reduce abdominal fat and blood pressure.